Bayesian meta-analyses for comparative effectiveness and informing coverage decisions

Medical Care

Volumn 48, Issue 6 SUPPL., 2010, Pages

  Berry, Scott M ^a   Ishak, K Jack ^b   Luce, Bryan R ^c   Berry, Donald A ^a,d  

^a Berry Consultants   (United States)

^b UNITED BIOSOURCE CORPORATION   (Canada)

^c UNITED BIOSOURCE CORPORATION   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bayesian analysis; Comparative effectiveness; Coverage decisions; Metaanalysis

Indexed keywords

ARTICLE; BAYESIAN LEARNING; COMPARATIVE STUDY; DATA EXTRACTION; DEFIBRILLATOR; FOLLOW UP; INSURANCE; MEDICAL DECISION MAKING; POLICY; PRIORITY JOURNAL; PROBABILITY; PUBLICATION; BAYES THEOREM; CLINICAL TRIAL; COMPARATIVE EFFECTIVENESS; GOVERNMENT; HUMAN; META ANALYSIS; METHODOLOGY; ORGANIZATION AND MANAGEMENT; UNITED STATES;

BAYES THEOREM; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); CLINICAL TRIALS AS TOPIC; COMPARATIVE EFFECTIVENESS RESEARCH; DEFIBRILLATORS, IMPLANTABLE; HUMANS; INSURANCE COVERAGE; META-ANALYSIS AS TOPIC; UNITED STATES;

EID: 77953644430     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181e24563     Document Type: Article

References (31)

1. United States Government Printing Office. H.R. 1- American Recovery and Reinvestment Act of 2009, Section 804. 111th United States Congress 1st Session. Available at: http://www.opencongress.org/bill/111-h1/show. Accessed July 1, 2009.
2. Hearing on Strategies to Increase Information on Comparative Clinical Effectiveness, 2007. Hearing before the Subcommittee on Health of the Committee on Ways and Means, US House of Representatives, 110th Cong, 1st Sess (2007). Available at: http://waysandmeans.house.gov/hearings.asp?formmode= detail&hearing=565. Accessed July 1, 2009.
3. Medicare Payment Advisory Commission. Report to the Congress: promoting greater eficiency in Medicare. Available at: http://www.medpac.gov/documents/ jun07-entirereport.pdf. Accessed July 1, 2009.
4. Medicare Payment Advisory Commission. Report to Congress: reforming thedeliverysystem. Availableat: http://www.medpac.gov/documents/Jun08- EntireReport.pdf. Accessed July 1, 2009.
5. Institute of Medicine of the National Academies. The Learning Healthcare System. Workshop Summary: roundtable on evidence- based medicine. Available at: http://books.nap.edu/openbook.php? Record-id=11903&page=R1. Accessed July 1, 2009.
6. Blue Cross and Blue Shield Association. Statement on Comparative Effectiveness Information Hearing, 2007: Hearing before the Subcommittee on Health of the Committee on Ways and Means, US House of Representatives. 110th Cong, 1st Session (2007). Available at: http://www.bcbs.com/issues/transparency/ background/bcbsa-statement-on.html. Accessed July 1, 2009.
7. America's Health Insurance Plans. Setting a higher bar: we believe there is more the nation can do to improve quality and safety in health care. Available at: http://www.ahipbelieves.com/media/Setting%20A%20Higher%20Ba%20- %20Improve%20Quality%20and%20Safety%20in%20Health%20Care.pdf. Accessed July 1, 2009.
8. Chalkidou K, Hoy A, Littlejohns P. Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research. J R Soc Med. 2007;100:453-460.
9. National Institute for Health and Clinical Excellence. Appraisal Consultation Document. Bortezomib for Relapsed Multiple Myeloma. Available at: http://www.nice.org.uk/guidance/index.jsp?action=article&r=true&o=35158. Accessed July 1, 2009.
10. Centers for Medicare & Medicaid Services, US Department of Health and Human Services. Nationals Coverage Determinations with Data Collection as a Condition of Coverage: Coverage with Evidence Development. Available at: http://www.cms.hhs.gov/mcd/ncpc-view-document.asp?id=8. Accessed July 1, 2009.
11. Agency for Healthcare Research and Quality, US Department of Health and Human Services. Use of Bayesian techniques in randomized clinical trials: a CMS case study. Technology assessments in progress. Available at: http://www.ahrq.gov/clinic/techix.htm#progress. Accessed July 1, 2009.
12. Ezekowitz JA, Rowe BH, Dryden DM, et al. Systematic review: implantable cardioverter defibrillators for adults with left ventricular dysfunction. Ann Intern Med. 2007;147:251-262.
13. Berry DA. Statistics: A Bayesian Perspective. Belmont, CA: Duxbury Press; 1996.
14. Berry DA, Stangl DK. Bayesian Biostatistics. New York, NY: Marcel Dekker; 1996.
15. Stangl DK, Berry DA. Meta-analysis in Medicine and Health Policy. New York, NY: Marcel Dekker; 2000.
16. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester, England: John Wiley & Sons; 2004.
17. Berry DA. Bayesian clinical trials. Nat Rev Drug Discov. 2006;5:27-36.
18. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med. 1996;335:1933-1940.
19. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
20. Bigger JT Jr; Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med. 1997;337:1569-1575.
21. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-1302.
22. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748-754.
23. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
24. Bansch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomypoathy Trial (CAT). Circulation. 2002;105:1453-1458.
25. Strickberger SA, Hummel JD, Bartlett TG, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol. 2003;41: 1707-1712.
26. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.
27. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
28. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488.
29. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [erratum in: N Engl J Med. 2005;352:2146].
30. N Engl J Med. 2005;352:225-237.
31. Berry SM, Berry DA, Natarajan K, et al. Bayesian survival analysis with nonproportional hazards: metanalysis of pravastatin-aspirin. J Am Stat Assoc. 2004;99:36-44.